Philip Dunne

40PUBLICATIONS
247CO-AUTHORS
Molecular targetsPredictive and prognostic markersRadiation therapyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|May 26, 2026
Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative state.

|May 06, 2026
Runx1 and Runx2 act in concert to suppress Wnt/β-catenin-driven mammary tumourigenesis.

|Feb 03, 2026
Smoking, alcohol, and colon cancer survival are modified by immune biomarkers: a population-representative study.

Yasemin Adali, Maurice B Loughrey, Stephanie Craig

|Jan 09, 2026
Differential Immunologic Effects of Short-Course and Long-Course Radiotherapy in Locally Advanced Rectal Cancer.

Lily V S Hillson, Ross K McMahon, Norman J Galbraith

|Dec 18, 2025
Nucleophosmin supports WNT-driven hyperproliferation and tumor initiation.

Georgios Kanellos, Chiara Giacomelli, Alexander Raven

|Nov 25, 2025
MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

Pageof 7

Frequent Collaborators

12 joint publications

Owen J Sansom

10 joint publications

Raheleh Amirkhah

9 joint publications

Andrew D Campbell

8 joint publications

Sudhir B Malla